Oxford Endovascular

About:

Oxford Endovascular are developing a novel treatment for treating brain aneurysms.

Website: http://www.oxfordendovascular.com

Top Investors: Innovate UK, Oxford Science Enterprises, Parkwalk Advisors, EASME - EU Executive Agency for SMEs, University of Oxford

Description:

Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.

Total Funding Amount:

$28.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Oxford, Oxfordshire, United Kingdom

Founded Date:

2015-01-01

Founders:

Mike Karim

Number of Employees:

1-10

Last Funding Date:

2024-05-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai